Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 1 August 2026.
Announcements
5,263
Total raised
£158B
disclosed amounts
The Scottish National Investment Bank led the Series A round to accelerate clinical validation and regulatory submission of the company's respiratory monitoring platform.
"We are delighted to close this round and thank both our existing investors and the Scottish National Investment Bank for their support,"
The Stoke-based company secured the capital from Mercia funds and private backers to develop its software and create new roles.
"With flexible working and the war for talent, the market for HRtech is expanding rapidly. Huler simplifies life for employees and enhances engagement and productivity. Nicky and Gareth have built an impressive client base and made inroads into the US market within their first year. The funding will help them drive further growth in the UK and internationally. It’s a pleasure to partner with Nicky, Gareth and the whole Huler team."
The investment brings the company's total seed funding to £6m and will support international growth.
"We’ve put ourselves in a very strong position to deliver on our ambitious 2023 objectives. I am grateful for the support of our new and existing investors and we’ll now continue to show them that they have made a brilliant choice."
The company has raised capital from international strategic and financial partners to accelerate its expansion across multiple industries.
"This landmark investment from world-class investors is a tremendous validation of our strategy to apply self-driving technology where there is persistent and urgent demand—in supply chains, industrial sectors, and in decongesting our cities."
The medtech startup will use the fresh capital to bring its pharmacist digitisation software to market.
"Using just an NHS number, we can create personalised, contextualised insights that will help people stay well. We’re so grateful to receive this additional Innovate UK backing so we can scale this application of our software and move a step closer towards creating a single source of truth for medicines data in the UK."
